ATA141786A - Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze - Google Patents

Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze

Info

Publication number
ATA141786A
ATA141786A AT0141786A AT141786A ATA141786A AT A141786 A ATA141786 A AT A141786A AT 0141786 A AT0141786 A AT 0141786A AT 141786 A AT141786 A AT 141786A AT A141786 A ATA141786 A AT A141786A
Authority
AT
Austria
Prior art keywords
salts
peptide compounds
producing new
new peptide
producing
Prior art date
Application number
AT0141786A
Other languages
English (en)
Other versions
AT396248B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA141786A publication Critical patent/ATA141786A/de
Application granted granted Critical
Publication of AT396248B publication Critical patent/AT396248B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/222—Foot and mouth disease related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT0141786A 1985-06-03 1986-05-27 Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze AT396248B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74078085A 1985-06-03 1985-06-03

Publications (2)

Publication Number Publication Date
ATA141786A true ATA141786A (de) 1992-11-15
AT396248B AT396248B (de) 1993-07-26

Family

ID=24978033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0141786A AT396248B (de) 1985-06-03 1986-05-27 Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze

Country Status (20)

Country Link
US (1) US4732971A (de)
EP (1) EP0204480B1 (de)
JP (1) JPS61282398A (de)
KR (1) KR890003944B1 (de)
CN (1) CN1019267B (de)
AT (1) AT396248B (de)
AU (1) AU595531B2 (de)
DE (1) DE3686095T2 (de)
DK (1) DK251286A (de)
EG (1) EG17812A (de)
ES (1) ES8707739A1 (de)
GR (1) GR861406B (de)
HK (1) HK101692A (de)
HU (1) HUT41050A (de)
IL (1) IL78913A (de)
NZ (1) NZ216362A (de)
PT (1) PT82651B (de)
SG (1) SG94792G (de)
SU (1) SU1662338A3 (de)
ZA (1) ZA863911B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
CN1059347C (zh) * 1992-03-27 2000-12-13 牧岩生命工学研究所 制备肾病综合症出血热疫苗的方法
CN1054544C (zh) * 1993-10-21 2000-07-19 复旦大学 家畜口蹄疫病毒多肽疫苗及其制备方法
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
US6048538A (en) * 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
EA003101B1 (ru) 1998-03-19 2002-12-26 Бристол-Майерз Сквибб Компани Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
RU2143921C1 (ru) * 1999-04-21 2000-01-10 Всероссийский научно-исследовательский институт защиты животных Вакцина против ящура типа а и способ ее изготовления
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
CN100342911C (zh) * 2004-01-13 2007-10-17 厦门大学 A、o型口蹄疫病毒双价dna疫苗及其制备方法
CN106974888B (zh) 2008-09-17 2019-08-02 克艾思马有限公司 药物组合物和相关的给药方法
WO2012006398A2 (en) 2010-07-09 2012-01-12 Bhv Pharma, Inc. Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
WO2014077825A1 (en) 2012-11-16 2014-05-22 United Biomedical, Inc. Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
DK3244920T5 (da) 2015-01-16 2024-10-07 Zoetis Services Llc Mund- og klovsyge-vaccine
CA2975599A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
CN107365367A (zh) * 2017-08-16 2017-11-21 山东省农业科学院奶牛研究中心 A型口蹄疫病毒vp1蛋白抗原表位基因多肽及其应用
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
WO2022221144A1 (en) * 2021-04-12 2022-10-20 University Of Washington Engineered peptides for αvβ6 integrin binding and related methods of use and synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
NO811609L (no) * 1980-05-12 1981-11-13 Biogen Nv Dna-sekvenser, rekombinante dna-molekyler, samt fremstilling av aktive polypeptider
EP0068693A3 (de) * 1981-06-16 1983-07-20 Genentech, Inc. Herstellung eines Maul- und Klauenseuche Impfstoffes aus mikrobiellen exprimierten Antigenen
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
DE3382459D1 (de) 1982-04-14 1991-12-19 James L Bittle Kuenstliches pikornavirusantigen.

Also Published As

Publication number Publication date
DK251286D0 (da) 1986-05-29
DK251286A (da) 1986-12-04
EP0204480A2 (de) 1986-12-10
ES555668A0 (es) 1987-08-16
SG94792G (en) 1992-12-04
US4732971A (en) 1988-03-22
EP0204480B1 (de) 1992-07-22
ZA863911B (en) 1988-01-27
AU595531B2 (en) 1990-04-05
HK101692A (en) 1992-12-24
AT396248B (de) 1993-07-26
DE3686095T2 (de) 1993-03-04
PT82651A (en) 1986-06-01
IL78913A0 (en) 1986-09-30
DE3686095D1 (de) 1992-08-27
NZ216362A (en) 1989-04-26
EP0204480A3 (en) 1989-02-08
CN1019267B (zh) 1992-12-02
SU1662338A3 (ru) 1991-07-07
ES8707739A1 (es) 1987-08-16
GR861406B (en) 1986-09-30
AU5821286A (en) 1986-12-11
KR890003944B1 (ko) 1989-10-13
CN86103718A (zh) 1987-02-04
PT82651B (pt) 1988-11-30
IL78913A (en) 1991-01-31
EG17812A (en) 1990-08-30
JPS61282398A (ja) 1986-12-12
HUT41050A (en) 1987-03-30
KR870000426A (ko) 1987-02-18

Similar Documents

Publication Publication Date Title
ATA141786A (de) Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
AT385758B (de) Verfahren zur herstellung von neuen cephemverbindungen und deren salzen
ATA257986A (de) Verfahren zur herstellung von neuen azetidinderivaten
ATA193185A (de) Verfahren zur herstellung von neuen substituierten benzamiden
ATA101986A (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
ATA144987A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
ATA273486A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
AT384218B (de) Verfahren zur herstellung von neuen chinazolin-derivaten
AT384810B (de) Verfahren zur herstellung von psoralenfreien neuen 6-alkylangelicinen und von deren salzen
AT384226B (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
ATA298586A (de) Verfahren zur herstellung von neuen anthracyclinglykosiden
AT381308B (de) Verfahren zur herstellung von neuen fluorprostacyclinen und von deren salzen
ATA313686A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
ATA36984A (de) Verfahren zur herstellung von neuen substituierten 2-phenylmethylen-1aminoalkyloximinocycloalkanen und deren saeureadditionssalzen
AT386407B (de) Verfahren zur herstellung von neuen n-sulfamyl -3-halogenpropionamidinen
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
ATA10886A (de) Verfahren zur herstellung von neuen proteinderivaten
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
AT386823B (de) Verfahren zur herstellung von neuen 4phenylpropylindolderivaten und ihren salzen
ATA154183A (de) Verfahren zur herstellung von neuen imidazochinoxalinen und von deren salzen
ATA223986A (de) Verfahren zur herstellung von neuen dihydropyridinderivaten
ATA29687A (de) Verfahren zur herstellung von neuen trifluormethyl substituierten tetracyclischen chinazolinonen und ihrer saeureadditionssalze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification